» Articles » PMID: 35556192

β-Actin: An Emerging Biomarker in Ischemic Stroke

Overview
Publisher Springer
Date 2022 May 13
PMID 35556192
Authors
Affiliations
Soon will be listed here.
Abstract

At present, the diagnosis of ischemic stroke mainly depends on neuroimaging technology, but it still has many limitations. Therefore, it is very important to find new biomarkers of ischemic stroke. Recently, β-actin has attracted extensive attention as a biomarker of a variety of cancers. Although several recent studies have been investigating its role in ischemic stroke and other cerebrovascular diseases, the understanding of this emerging biomarker in neurology is still limited. We examined human and preclinical studies to gain a comprehensive understanding of the literature on the subject. Most relevant literatures focus on preclinical research, and pay more attention to the role of β-actin in the process of cerebral ischemia, but some recent literatures reported that in human studies, serum β-actin increased significantly in the early stage of acute cerebral ischemia. This review will investigate the basic biology of β-actin, pay attention to the potential role of serum β-actin as an early diagnostic blood biomarker of ischemic stroke, and explore its potential mechanism in ischemic stroke and new strategies for stroke treatment in the future.

Citing Articles

Ischemic Postconditioning Regulates New Cell Death Mechanisms in Stroke: Disulfidptosis.

Liu S, Wu Q, Xu C, Wang L, Wang J, Liu C Biomolecules. 2024; 14(11).

PMID: 39595569 PMC: 11591815. DOI: 10.3390/biom14111390.


Novel metabolic biomarkers for the diagnosis of acute ischemic stroke.

Tang Z, Xu B, Wang J, Wang W, Sha S, Sun Y Biomark Med. 2024; 18(17-18):727-737.

PMID: 39235047 PMC: 11457651. DOI: 10.1080/17520363.2024.2389033.

References
1.
Holford N, Ramoutar A, Butt A, Swaminathan R . Normalization of circulating nucleic acid results. Ann N Y Acad Sci. 2008; 1137:112-8. DOI: 10.1196/annals.1448.000. View

2.
Bellani S, Mescola A, Ronzitti G, Tsushima H, Tilve S, Canale C . GRP78 clustering at the cell surface of neurons transduces the action of exogenous alpha-synuclein. Cell Death Differ. 2014; 21(12):1971-83. PMC: 4227148. DOI: 10.1038/cdd.2014.111. View

3.
Li Y, Chopp M, Zhang Z, Zaloga C, Niewenhuis L, Gautam S . p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke. 1994; 25(4):849-55; discussion 855-6. DOI: 10.1161/01.str.25.4.849. View

4.
Cohen I, Kaminski E, Glaser T . Actin and myosin from blood platelets or muscle are potent aggregating agents. Thromb Res. 1976; 8(3):383-92. DOI: 10.1016/0049-3848(76)90031-1. View

5.
Yu I, Kuo P, Yen J, Paraiso H, Curfman E, Hong-Goka B . A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury. Transl Stroke Res. 2017; 8(6):560-577. DOI: 10.1007/s12975-017-0543-5. View